Vaxart Inc filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
|
|
|
||
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
||
|
|
|||
(Address of principal executive offices)
|
(Zip Code)
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading symbol
|
Name of each exchange on which registered
|
||
|
|
The
|
Item 8.01
|
Other Events.
|
Item 9.01
|
Financial Statements and Exhibits.
|
Exhibit
|
Description
|
|
99.1 | Press Release, dated April 30, 2024. | |
104
|
Cover Page Interactive Data File (embedded within Inline XBRL document).
|
Vaxart, Inc.
|
|||||||
Dated: April 30, 2024
|
|||||||
By:
|
/s/ STEVEN LO
|
||||||
Steven Lo
|
|||||||
President and Chief Executive Officer
|